Delivery Order SPE2DB20D3101-SPE2DB25FRBW1

Award Date 2/13/25
Potential Completion Date 2/14/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,157.66 firm fixed-price delivery order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The award has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,025.30 firm-fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,559.05 Firm Fixed Price Delivery Order contract is for the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $18,498.58, is a Delivery Order contract with a Firm Fixed Price pricing type. It covers the provision of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of December 12, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,384.53 firm fixed-price delivery order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and does not utilize any set-aside designations. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $8,723.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an Ultimate Completion Date of June 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,520.51 Firm Fixed Price Delivery Order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract has an ultimate completion date of December 5, 2024 and was awarded on December 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,601.54 Delivery Order contract is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement with an ultimate completion date of June 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,736.60 firm fixed-price delivery order contract has a completion date of June 17, 2024 and is for the supply of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,900.67, is a delivery order for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRBW1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,830.33, is a Firm Fixed Price Delivery Order for the supply of NURTEC ODT 75 MG TABLET 8S medical products. The contract has an ultimate completion date of February 14, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with any set-aside requirements, indicating open competition.

Generated 5/22/25, 8:12 PM